EE312 Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Stabilized Prefusion F Subunit Vaccine (RSVpreF) in Pregnant Individuals for the Prevention of Respiratory Tract Disease (RTD) Caused by RSV Among Infants in Canada
Abstract
Authors
A Goyette A Averin E Kutrieb E Quinn M Atwood D Weycker Beltrán AG Grajales A Law